CUE HEALTH INC. Form 8-K (Jan. 11, 2022)

Summary

Current report on Form 8-K of Cue Health Inc. reporting an event dated January 11, 2022. Under Item 2.02 the company states that it announced certain preliminary financial results for the fourth quarter and year ended December 31, 2021, and that the results remain subject to completion of its internal review and its independent auditor's audit, with possible revisions, some of which may be material. Item 7.01 says the company intends to present at the J.P. Morgan Healthcare Conference on January 11, 2022. The press release is Exhibit 99.1, and /s/ John Gallagher, Chief Financial Officer, signed January 11, 2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

8-K 1 cuehealth8-k11122.htm 8-K html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 11, 2022

CUE HEALTH INC.

(Exact name of Registrant, as specified in its charter)

Delaware | 001-40590 | 27-1562193
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number)

Mailing address:

4980 Carroll Canyon Rd.

Suite 100

San Diego, CA 92121

(Address of principal executive

offices)

Registrant's telephone number, including area code: (858) 412-8151

Former name or address, if changed since last report: Not Applicable.

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, par value $0.00001 per share | HLTH | Nasdaq Global Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On January 11, 2022, Cue Health Inc. (the “Company”), announced certain preliminary financial results for the fourth quarter and year ended December 31, 2021. The preliminary results remain subject to the completion of the Company's internal review of its financial results and its independent auditor's completion of their audit of the Company's financial statements and potential revisions resulting therefrom, some of which may be material. A copy of the press release is furnished as Exhibit 99.1 to this report.

Item 7.01. Regulation FD Disclosure.

On January 11, 2022, the Company intends to make a presentation (the "Presentation") at the J.P. Morgan Healthcare Conference (the "Conference"), a copy of which can be found at the Company's website at https://investors.cuehealth.com in advance of presenting at the Conference and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K and in the accompanying exhibit are “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. | Description
99.1 | Press Release dated January 11, 2022.
104 | Cover Page Interactive Data File (embedded within the Inline XBRL Document).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: 1/11/2022

Cue Health Inc.

By: | /s/ John Gallagher
Name: | John Gallagher
Title: | Chief Financial Officer

3

File and source

File

SEC_CUE_8-K_filed2022-01-11_0001628945-22-000009.htm

Size

25,453 bytes

SHA-256

2b9aa852615d184f229612c8dca7be94ff3a2cdb7c3342bab5be5dab7df0c47e

Our copy

SEC_CUE_8-K_filed2022-01-11_0001628945-22-000009.htm

Original

www.sec.gov